Omeros Corporation (NASDAQ: OMER) Now Has A Market Cap Nearing $683.23M But Is Projected To Reach $122.26 million By 2025

Omeros Corporation (NASDAQ:OMER) does about 589.43K shares in volume on a normal day but saw 2104633 shares change hands in the recent trading day. The company now has a market cap of 683.23M USD. Its current market price is $11.79, marking an increase of 8.07% compared to the previous close of $10.91. The 52 week high reached by this stock is $10.99 whilst the lowest price level in 52 weeks is $1.81. The script in recent trading has seen the stock touch a high of $2 and a low of $2.

Omeros Corporation (OMER) has a 20-day trading average at $5.68 and the current price is 7.28% off the 52-week high compared with 551.17% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.66 and its 200-day simple moving average is $4.14. If we look at the stock’s price movements over the week, volatility stands at 21.29%, which decreases to 12.42% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 87.52 to suggest the stock is overbought.

1 analysts observing the Omeros Corporation (OMER) stock have set the 12-month price targets for the company’s shares at between $2 and $2. The consensus objective for the share price is $9.00, suggesting that the stock has a potential downside of -31.0% over the period. The median price target is -489.5% away from the current levels at $2.

FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Moderate Buy the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 14, 2024 when Rodman & Renshaw initiated the stock to “Buy” and issued a price target of $9. UBS downgraded the stock to “Neutral” from Buy on December 08, 2022 at a price target of $12-$2. BofA Securities downgraded its price target at $8-$3.

The current price level is 107.59%, 152.86%, and 184.98% away from its SMA20, SMA50, and SMA200 respectively, with the OMER price moving below the 50-day SMA on current market day. Omeros Corporation (OMER) stock is up 99.16% over the week and 181.38% over the past month. Its price is 260.55% year-to-date and 540.76% over the past year.

The stock last released its quarterly earnings report for quarter ended 9/30/2024, with the company’s earnings per share (EPS) of -0.69 below consensus estimates by -0.04. The company’s next earnings report forecasts estimating quarterly EPS at -0.82 and -3.15 for whole year.

Its 12-month price target is $2. To reach the target analysts have set, the stock logically needs to shrink -31.0 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $2, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $2.

Outstanding shares total 61.13M with insiders holding 4.44% of the shares and institutional holders owning 43.73% of the company’s common stock. The company has a return on investment of -52.83% and return on equity of -576.33%. The beta has a value of 1.84.